RAPPORT THERAPEUTICS INC
RAPP·75383L102·US·Common Stock·Healthcare - Biotechnology-Activist
RAPP (RAPPORT THERAPEUTICS INC) is held by 91 institutional investors as of Q1 2026. Largest holders: FMR LLC ($224.3M), Capital International Investors ($96.9M), GOLDMAN SACHS GROUP INC ($92.1M). Net institutional sentiment: Mixed.
91
Holders
Avg rating(18 Elite)
$916M
Total Value
62% (100)
Fund Consensus
55 buying - 34 selling
Who's Trading
InsiderTLThird Rock Ventures V, L.P.Sell $744KMay 26, 2026
ActivistCACormorant Asset Management, LP6.2%May 15, 2026
InsiderTLThird Rock Ventures V, L.P.Sell $202KMay 8, 2026
InsiderTLThird Rock Ventures V, L.P.Sell $10.9MMay 7, 2026
InsiderTLThird Rock Ventures V, L.P.Sell $17.2MApr 17, 2026
InsiderYKYeleswaram KrishnaswamySell $809KApr 17, 2026
InsiderYKYeleswaram KrishnaswamySell $358KApr 14, 2026
InsiderYKYeleswaram KrishnaswamySell $321KApr 13, 2026
InsiderYKYeleswaram KrishnaswamySell $17KApr 10, 2026
13F: Insider & Congress:
Showing 1-20 of 100
1 / 5
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer